MHRA & Department for Education Embed Medicine Safety Into School Curriculum The importance of medicine safety and how to report side effects of medicines via the Yellow Card scheme is now part of the statutory guidance for schools in England. MHRA & Department for Education Embed Medicine Safety Into School Curriculum
MHRA Blog – Looking to Our Future: Reflections on the Strategic Choices Ahead for the MHRA MHRA is publishing a series of blogs on the challenges and opportunities ahead. In the first instalment, Chief Executive Lawrence Tallon reflects on the changing healthcare landscape, the regulator’s role, and the priorities shaping the agency’s future direction. MHRA Blog – Looking to Our Future: Reflections on the Strategic Choices Ahead for the MHRA
DHSC Public Appointments The Department of Health and Social Care (DHSC) has published information about non-executive appointments to DHSC's public bodies and committees in September 2025. DHSC Public Appointments
MHRA – Additional Information for Change of Ownership MHRA has added additional information on change of ownership in the guidance 'apply for manufacturer or wholesaler of medicines licences' which contains information on how to apply for, update and cancel licences for the manufacture, import and wholesale of human and veterinary medicines. MHRA – Additional Information for Change of Ownership
European Commission Consultation – GMP Guidelines Chapter 1: Pharmaceutical Quality System The European Commission has launched a public consultation on a revised Good Manufacturing Practice (GMP) Chapter 1: Pharmaceutical Quality System. The deadline is 3 December 2025. European Commission Consultation – GMP Guidelines Chapter 1: Pharmaceutical Quality System
MHRA – Parallel Import Variation Tell-and-Do (TaD) Cover Sheet MHRA has updated the 'Parallel Import Variation Tell-and-Do (TaD) Cover Sheet' in the guidance 'medicines: apply for a parallel import licence'. MHRA – Parallel Import Variation Tell-and-Do (TaD) Cover Sheet
EMA ICH Consultation – Q3E Draft Guideline for Extractables and Leachables & Supporting Documentation The European Medicines Agency (EMA) has published for public consultation the draft International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Q3E Guideline for extractables and leachables and ICH Q3E Guideline for extractables and leachables - supporting documentation: class 3 leachable monographs. EMA ICH Consultation – Q3E Draft Guideline for Extractables and Leachables & Supporting Documentation
Exclusive Webinar – Understanding the Life Sciences Innovative Manufacturing Fund (LSIMF) The OLS and PAGB are hosting a special webinar, exclusive to PAGB members, marking one year since the launch of the Life Sciences Innovative Manufacturing Fund (LSIMF) Exclusive Webinar – Understanding the Life Sciences Innovative Manufacturing Fund (LSIMF)
10-Year Health Plan – Parallel Decision Making over Licencing (MHRA) and Value (NICE) The MHRA and the National Institute for Health and Care Excellence (NICE) have described how the 10-Year Health Plan will lead to faster new medicines access for patients in the NHS in England, through parallel decision making over licencing and value 10-Year Health Plan – Parallel Decision Making over Licencing (MHRA) and Value (NICE)
DHSC – Industry Placements The Department of Health and Social Care (DHSC) has run over 30 placements with more than 150 DHSC colleagues since last year. DHSC is now looking to secure new placements. DHSC – Industry Placements
New Chief Executive Appointed at UKHSA The government has announced the appointment of Professor Susan Hopkins as the new CEO of the UK Health Security Agency (UKHSA). New Chief Executive Appointed at UKHSA
TOPRA Course: CRED Prescription to Non-Prescription Medicines Switch in EU PAGB's CEO Michelle Riddalls OBE will be presenting at a new TOPRA course ‘CRED Prescription to Non-Prescription Medicines Switch in EU’ which will take place online on 8 October between 9:15am – 5pm (GMT). TOPRA Course: CRED Prescription to Non-Prescription Medicines Switch in EU
